Lexeo Therapeutics posts updated corporate presentation; no material new information in 8-K

Lexeo Therapeutics, Inc.

Updated corporate presentation posted on website January 13, 2025, for investor and analyst meetings.
Presentation includes forward-looking statements on gene therapy trial plans and data timing.
No financial results, leadership changes, or other material events disclosed in this filing.
Risk factors from prior SEC filings are incorporated by reference.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.